Skip to main content

Table 2 Numbers, proportions and estiamted incidence rates (per 100,000 doses) of AEFIs by vaccine in Jiangsu, China

From: The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015–2018

Vaccine

Common Vaccine Reaction

Rear Vaccine Reaction

AEFI

No. of cases

proportion(%)

Estimated incidence

No. of cases

proportion(%)

Estimated incidence

No. of cases

proportion(%)

Estimated incidence

BCG

295

0.408

7.33

346

6.521

8.60

658

0.84

16.35

HepB (CHO)

116

0.160

11.48

14

0.264

1.39

131

0.17

12.96

HepB (YEAST)

3787

5.234

33.10

192

3.619

1.68

4017

5.15

35.11

tOPV

402

0.556

6.85

54

1.018

0.92

464

0.60

7.91

IPV (Sabin)

363

0.502

65.01

34

0.641

6.09

401

0.51

71.82

IPV (Salk)

645

0.891

25.28

70

1.319

2.74

736

0.94

28.84

bOPV

917

1.267

13.52

125

2.356

1.84

1054

1.35

15.54

DTaP

29,464

40.719

198.58

757

14.267

5.10

30,278

38.84

204.07

DT*

5905

8.161

166.41

61

1.150

1.72

5974

7.66

168.35

Tetanus

1

0.001

1.30

1

0.019

1.30

2

0.00

2.60

MV

298

0.412

126.95

108

2.035

46.01

410

0.53

174.67

MMR

1821

2.517

43.09

301

5.673

7.12

2131

2.73

50.42

MM

7

0.010

57.27

0

0.000

0.00

7

0.01

57.27

MR

4717

6.519

121.11

1821

34.320

46.76

6558

8.41

168.38

MPV-A

7811

10.795

100.49

316

5.956

4.07

8153

10.46

104.89

MPV-AC

2776

3.836

38.18

164

3.091

2.26

2952

3.79

40.60

MPCV-AC

83

0.115

32.43

6

0.113

2.34

89

0.11

34.78

MPV-ACYW135

64

0.088

38.60

3

0.057

1.81

68

0.09

41.01

JEV-L

3754

5.188

46.34

328

6.182

4.05

4089

5.25

50.48

JEV-I

80

0.111

49.35

7

0.132

4.32

87

0.11

53.67

HepA-L

1

0.001

0.42

0

0.000

0.00

1

0.00

0.42

HepA-I

2198

3.038

28.41

136

2.563

1.76

2339

3.00

30.23

HepAB

20

0.028

34.40

1

0.019

1.72

21

0.03

36.12

InfV

539

0.745

41.40

34

0.641

2.61

579

0.74

44.47

VarV

824

1.139

38.95

100

1.885

4.73

932

1.20

44.06

Hib

956

1.321

74.17

64

1.206

4.97

1020

1.31

79.13

ORV

109

0.151

27.58

7

0.132

1.77

117

0.15

29.61

PPV23

845

1.168

242.66

21

0.396

6.03

867

1.11

248.98

PCV7

23

0.032

95.73

6

0.113

24.97

29

0.04

120.70

PCV13

219

0.303

127.33

16

0.302

9.30

236

0.30

137.21

RabV

1037

1.433

5.11

76

1.432

0.37

1123

1.44

5.53

DTap-Hib

274

0.379

169.66

12

0.226

7.43

286

0.37

177.09

DTaP-IPV-Hib

1309

1.809

251.27

34

0.641

6.53

1349

1.73

258.94

HepE

6

0.008

29.19

0

0.000

0.00

6

0.01

29.19

MPV-AC/Hib

132

0.182

51.98

13

0.245

5.12

145

0.19

57.10

EV71(Human Diploid)

282

0.390

34.39

40

0.754

4.88

328

0.42

40.01

EV71(Vero)

249

0.344

64.83

31

0.584

8.07

283

0.36

73.68

B-HPV

14

0.019

9.23

3

0.057

1.98

18

0.02

11.87

Q-HPV

16

0.022

10.12

4

0.075

2.53

21

0.03

13.28

Total

72,359

100.000

60.68

5306

100.000

4.45

77,959

100.00

65.38